Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-Cycloserine Augmentation of CBT for Delusions
NCT01981759Phase 4Completed
- Sponsor
- NYU Langone Health
- Start
- Feb 2014
- Primary completion
- May 2017
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of d-cycloserine in schizophrenia, schizoaffective disorder, delusional disorder, sponsored by NYU Langone Health. Started Feb 2014; status: completed.
02
Drugs
d-cycloserine
03
Conditions
schizophreniaschizoaffective disorderdelusional disorder
Beyond the preview
Go deeper on NCT01981759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01981759.